Deprescribing of antipsychotics of patients with dementia in long term care - an intervention study
Not Applicable
- Conditions
- F03Unspecified dementia
- Registration Number
- DRKS00017831
- Lead Sponsor
- Medizinische Fakultät der TU München, Klinik und Poliklinik für Psychiatrie und Psychotherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting stopped after recruiting started
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Person with dementia living in long term care for at least six months;
- Person has been treated with at least one AP for at least three months for the treatment of neuropsychiatric symptoms as part of dementia (including sleep disorders), which can be deprescribed with low risk.
- Deprescribing AP indicated.
- Informed consent of the resident or his legal representative available
- Close relative with sufficient knowledge of German ready to participate in the study
Exclusion Criteria
- Indication of treatment with AP is not neuropsychiatric symptoms in dementia but e.g. schizophrenia.
-Severe disease that makes survival until the end of the study unlikely.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint of the study is the estimation of the relative frequency with which anti-psychotics deprescribing recommendations are partially or fully implemented by the treating physician.
- Secondary Outcome Measures
Name Time Method In addition to the investigation of the primary endpoint, the statistical analysis also includes pre-post comparisons with regard to the state of the patients before and after AP therapy.<br>In addition, an analysis of the reasons that prevented physicians from implementing the antipsychotic deprescribing recommendation is performed, supplemented by a description of the patients with and without implementation of the recommendations by descriptive statistics.